Kyle Kiser, CEO of Arrive Health, discusses the pressing issue of prescription affordability and the gaps in medication access faced by many Americans. He highlights how point-of-prescribing technology can bridge these gaps and enhance patient care through real-time data. The conversation touches on the evolving role of pharmaceutical support programs and the potential of biosimilars to lower costs. Kiser emphasizes the importance of integrating consumer choice into healthcare decision-making to empower patients and streamline access to necessary medications.
22:41
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
High Deductibles Shift Costs
Nearly everyone has drug benefits, but high deductibles shift costs to patients, making them effectively cash payers.
The rise in drug prices is compounded by this cost burden shift to consumers.
insights INSIGHT
Complexity Raises Patient Costs
Insurance plan complexities lead to high out-of-pocket costs even for generics.
Doctors often lack visibility into affordable alternatives at prescribing time.
insights INSIGHT
Improving Prior Authorization Process
Prior authorization use has increased, creating more friction for providers.
Real-time decision support can streamline approvals to get the right medication prescribed initially.
Get the Snipd Podcast app to discover more snips from this episode
Nearly all insured Americans have prescription medication benefits.
So why are so many Americans struggling to afford those prescriptions?
Shouldn't these benefits cover the cost?
In this episode of CareTalk, David Williams speaks with Kyle Kiser, CEO of Arrive Health, to explore the factors driving the disconnect between consumer needs and prescription pricing, and how point-of-prescribing technology can serve as a patient-centered solution.
This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.
As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
TOPICS (0:17) Sponsorship (2:01) Why Is Medication Access an Issue? (4:23) What Happened to Affordable Medicine? (5:14) The State of Prior Authorization (7:08) Why Hasn't Electronic Prescribing Solved Consumer Constraints? (8:58) What Is Patient-Centered, Provider-Friendly Tech? (13:18) The Issues with Preferred Pharmacies (15:34) How Have Pharma Support Programs Evolved? (18:12) The Role of Biosimilars in Reducing Prices (19:38) What Should a Patient Know When Dealing with Prescription Costs?
🎙️⚕️ABOUT CARETALK CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
🎙️⚕️ABOUT KYLE KISER Kyle Kiser became CEO of Arrive Health in 2021, having previously served as its President and Chief Strategy Officer for over four years. Under his leadership, Arrive Health has built a network of top health systems, health plans, PBMs, and IT vendors to enhance patient access, affordability, and outcomes while minimizing administrative burdens. Before joining Arrive Health, Kyle held senior roles at Welltok, Catapult Health, and Principal Wellness Company.
🎙️⚕️ABOUT ARRIVE HEALTH Arrive Health is dedicated to improving patient affordability and access to care, and this new brand exemplifies its ambitions and purpose in a more unique way. They are wholly focused on integrating accurate data—encompassing pharmacy, medical benefits, and more—into provider and care team workflows, ensuring that patients receive the highest quality care at the most affordable price.
CareTalk: Healthcare. Unfiltered. 